Epilepsy, a chronic neurological disorder characterized by recurrent, unprovoked seizures, has seen significant advancements in its management over recent years. This article aims to provide a comprehensive update on these recent developments.
Several new AEDs have been introduced in the last decade. These drugs, including Brivaracetam, Perampanel, and Stiripentol, offer improved seizure control, better tolerability, and fewer drug interactions. They have broadened the therapeutic options for clinicians, particularly for refractory epilepsy.
There has been a significant evolution in epilepsy surgery. Minimally invasive techniques, such as laser interstitial thermal therapy (LITT) and stereotactic EEG-guided resection, have demonstrated efficacy in reducing seizure frequency and severity. These techniques offer a safer and more tolerable alternative to traditional resective surgery.
Neuromodulation therapies, including vagus nerve stimulation (VNS), responsive neurostimulation (RNS), and deep brain stimulation (DBS), have emerged as promising treatment options for drug-resistant epilepsy. These therapies modulate neuronal activity, reducing seizure frequency and improving quality of life.
Advancements in genetic testing have led to the identification of numerous epilepsy-associated genes, facilitating precision medicine. Tailoring treatment based on a patient's genetic profile can optimize efficacy and minimize adverse effects, offering a personalized approach to epilepsy management.
In conclusion, the field of epilepsy management has seen significant advancements, with new AEDs, improved surgical techniques, neuromodulation therapies, and the advent of precision medicine. These developments have expanded treatment options, improved patient outcomes, and provided a more personalized approach to care. It is essential for healthcare professionals to keep abreast of these advancements to provide optimal care to their patients.
1.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
2.
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
3.
Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study
4.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
5.
Long-Acting Interferon Therapy Approved for ET
1.
Molecular Network Mapping in Hematologic Disease
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
4.
Connected Hematology Laboratory Networks for Automated Cross-Institution Data Exchange
5.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Common side effects of cancer treatment and how they are managed
3.
Clinical Excellence in Hematology
4.
Best Practices in Hematology
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation